BIO 2025: The “RNAissance” Era: Recent Breakthroughs, Future Prospects, and Challenges of RNA Therapeutics
Jean Ge will moderate a panel titled “The ‘RNAissance’ Era: Recent Breakthroughs, Future Prospects, and Challenges of RNA Therapeutics” at the 2025 BIO International Convention. In this session, leaders of the RNA therapeutics field will review the recent breakthroughs in technical and clinical developments that unlock the therapeutic potential of RNA, and the increased investment opportunities that fuel the rapid growth of the field.
PANELISTS:
- Oxana Beskrovnaya, Chief Innovation Officer, Dyne Therapeutics
- Jill Goldstein, Principle, Vida Ventures
- Benjamin Kim, PhD, Partner, Playground Global
- Sacha Mann, Experienced VC / Board Member / CEO / Company Builder, Stealth Biotech
- Samir Ounzain, PhD, Chief Executive Officer & Scientific Co-Founder, HAYA Therapeutics